Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alkermes plc.ALKS · Entity 2392 | Director | May 20, 2026 | May 23, 2026 |
| MIMEDX GROUP, INC.MDXG · Entity 5271 | Director | June 18, 2025 | June 23, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alkermes plc.
Report date May 20, 2026 · Filed May 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 33,769 |
Ending reported balance
After 2026-05-21 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-21 · Exercise / conversion · Acquired 6,142 · Balance 35,244 F1: Each restricted stock unit represents a contingent right to receive one ordinary share. Row 2 · 2026-05-21 · Tax withholding · Disposed 1,475 · Balance 33,769 |
| Non Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.98 · Expires 2036-05-20 | Direct | 11,538 |
Reported balance
After 2026-05-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-20 · Grant · Acquired 11,538 · Balance 11,538 F2: Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant. |
| Restricted Stock Unit AwardSEC Table II · derivative / convertible security | Direct | 5,409 |
Reported balance
After 2026-05-20 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-05-20 · Grant · Acquired 5,409 · Balance 5,409 F1: Each restricted stock unit represents a contingent right to receive one ordinary share. F2: Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant. |
| Restricted Stock Unit AwardSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-21 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-05-21 · Exercise / conversion · Disposed 6,142 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one ordinary share. F3: This award is fully vested in accordance with its terms. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one ordinary share.
F2: Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant.
F3: This award is fully vested in accordance with its terms.
MIMEDX GROUP, INC.
Report date June 18, 2025 · Filed June 23, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 181,923 |
Reported balance
After 2025-06-18 transaction · row 1
1 source rowRow 1 · 2025-06-18 · Grant · Acquired 28,609 · Balance 181,923 F1: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders |
Filing footnotes · ownership attribution and instrument terms
F1: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 08, 2022 Filed Dec 9, 2022 22:18 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 4,082 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-027226 · form4.xml · nonDerivative · entry 3 LAURENCIN CATO T · CIK 0001444810 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,857 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| December 08, 2022 Filed Dec 9, 2022 22:18 UTC | Alkermes plc. ALKS · Entity 2392 | Tax withholdingOrdinary Shares | 385 | $25.48 | $9,809.80 |
DisclosureSEC source: 0001127602-22-027226 · form4.xml · nonDerivative · entry 2 LAURENCIN CATO T · CIK 0001444810 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,775 Read SEC document |
| December 08, 2022 Filed Dec 9, 2022 22:18 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 4,160 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-027226 · form4.xml · nonDerivative · entry 1 LAURENCIN CATO T · CIK 0001444810 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,160 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| July 07, 2022 Filed Jul 8, 2022 20:22 UTC | Alkermes plc. ALKS · Entity 2392 | GrantNon Qualified Stock Option (Right to Buy) · Derivative | 11,554 | $0.00 Strike: $31.48 | $0.00 |
DisclosureSEC source: 0001127602-22-019130 · form4.xml · derivative · entry 2 LAURENCIN CATO T · CIK 0001444810 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,554 Underlying: Ordinary Shares · 11,554 shares Expires 2032-07-07 F3 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 7/7/2023. Read SEC document |
| July 07, 2022 Filed Jul 8, 2022 20:22 UTC | Alkermes plc. ALKS · Entity 2392 | GrantRestricted Stock Unit Award · Derivative | 5,957 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-019130 · form4.xml · derivative · entry 1 LAURENCIN CATO T · CIK 0001444810 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,957 Underlying: Ordinary Shares · 5,957 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 7/7/2023. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 7/7/2023. Read SEC document |
| June 07, 2022 Filed Jun 13, 2022 22:41 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 44,191 | $3.96 | $174,996.36 |
DisclosureSEC source: 0001444810-22-000004 · wf-form4_165516005258655.xml · nonDerivative · entry 1 LAURENCIN CATO T · CIK 0001444810 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,770 F1 · shares: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders. Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 21:36 UTC | Alkermes plc. ALKS · Entity 2392 | GrantNon Qualified Stock Option (Right to Buy) · Derivative | 23,739 | $0.00 Strike: $22.97 | $0.00 |
DisclosureSEC source: 0001127602-21-030721 · form4.xml · derivative · entry 4 LAURENCIN CATO T · CIK 0001444810 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,739 Underlying: Ordinary Shares · 23,739 shares Expires 2031-12-08 F5 · derivative.exercise_date: Shares subject to the stock option award vest in three annual installments commencing on 12/8/2022. Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 21:36 UTC | Alkermes plc. ALKS · Entity 2392 | GrantRestricted Stock Unit Award · Derivative | 12,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-030721 · form4.xml · derivative · entry 3 LAURENCIN CATO T · CIK 0001444810 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,245 Underlying: Ordinary Shares · 12,245 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F4 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in three annual installments commencing on 12/8/2022. F4 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in three annual installments commencing on 12/8/2022. Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 21:36 UTC | Alkermes plc. ALKS · Entity 2392 | GrantNon Qualified Stock Option (Right to Buy) · Derivative | 8,400 | $0.00 Strike: $22.97 | $0.00 |
DisclosureSEC source: 0001127602-21-030721 · form4.xml · derivative · entry 2 LAURENCIN CATO T · CIK 0001444810 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,400 Underlying: Ordinary Shares · 8,400 shares Expires 2031-12-08 F3 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 12/8/2022. Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 21:36 UTC | Alkermes plc. ALKS · Entity 2392 | GrantRestricted Stock Unit Award · Derivative | 4,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-030721 · form4.xml · derivative · entry 1 LAURENCIN CATO T · CIK 0001444810 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,160 Underlying: Ordinary Shares · 4,160 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 12/8/2022. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 12/8/2022. Read SEC document |
| May 27, 2021 Filed May 28, 2021 18:35 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 17,056 | $10.26 | $174,994.56 |
DisclosureSEC source: 0001444810-21-000002 · wf-form4_162222691787921.xml · nonDerivative · entry 1 LAURENCIN CATO T · CIK 0001444810 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,579 F1 · kind: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders. Read SEC document |
| December 16, 2020 Filed Dec 18, 2020 12:50 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 11,174 | $7.83 | $87,492.42 |
DisclosureSEC source: 0001376339-20-000157 · wf-form4_160829579403043.xml · nonDerivative · entry 2 LAURENCIN CATO T · CIK 0001444810 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,523 F2 · shares: Grant of restricted stock which vests in full on the earlier of one year from the grant date or on the date of the Company's next Annual Shareholders Meeting. Read SEC document |
| December 16, 2020 Filed Dec 18, 2020 12:50 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 22,349 | $7.83 | $174,992.67 |
DisclosureSEC source: 0001376339-20-000157 · wf-form4_160829579403043.xml · nonDerivative · entry 1 LAURENCIN CATO T · CIK 0001444810 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,349 F1 · shares: Grant of restricted stock which vests in equal parts over three years from the date of the grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.